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The $ntmt&ion of echucardiographic coolrust medium 
attd the cyclic clanga lo ktl ventricular W&density 
doring trnngnrtmuoary mntrast &urardiugrnphy were 
tmatiw~$ed in rdnc adult vuhmteers \ri$h the use of intra- 
v@tt~ittj~$$mts of sotdca$@d albumln (microbubble size 
5.2 * 2.6 rm). Right nnd letl ventrlrulnr and myuawdiul 
mntrlt wm quattti$a$ed by vtdeudensitometric analysis. 
The ittjec$lotts caused no symptoms, and no henwdy. 
namic or @kc$mcwJiaxrauhic chmw were observed. All I . 
htJectkas res”ned in right “essmcular Cmdr st.Main peak 
rkht vetdxkular vid~ensit~ was 75 f 48 at etidisrtole 
id 61 t M gray scale U/pixel nt end.sys$ul@ (p < 0.05). 
8evetdy+lt$ prtwtt oi injections resulted in Ml ventric- 
ular coohut with a ntean pak ridwdemity of 21 + 33 
gray wale U/pixel. Early systule was awdated with u rapid 
dcnrsl* $u $@R veutrkdar cuntmst intensity wiul near Lot* 
Transmission of echocardiographic contrast medium 
through the lungs after intravenous injection with resulting 
opacification of the left ventricle and myacardium has been 
agoal ofechocardiographers for years (l-4). The reason that 
most ultrasonic contrast medium is removed by the lungs 
after intravenous injwtion was described by us in 1980 (5): 
microbubbles larger than about 8 pm in diameter are trapped 
by the “sieve” action of the pulmonary capillary bed and 
those small enough to Row through the capillaries will 
dissolve because of surface !:nsion effects in less time than 
the transit time from the pulmonary cspillaries to the left 
disappearance ufcwWus$ by @ml-s)stole lims C t 33 and 
17 I 23 U/pixel at ettd.diastoie tu 6 + 10 and : 2 2 at 
end-systale a$ the left venticutu base and apex. rest 
,$“@I,: p < 0.05,. Nan@ of the l”&tMns resulted in m,o- 
cardial ~untrast etdxmwnent by visual ur quantitative 
n&sir. 
Thus. left ventricular cuntrust &xardiagrsphy cno be 
uchieved after in$rav@ouus iqjxtiotts oi sonicnted albumin. 
Trsnspulmonarv kit ventricular cnon$rS$ echocnrdiw 
ruphy’is ass&ted with near total disappearance of r&. 
trust durinr susble. Tbis may be secmtdsry to the destruc- 
tion of mi&bubbks by the high l@R ventrktdar systatic 
prewr@. These Bndings mug help explaiu the limltd 
success 01 this tectmiqne thus far fur myccardii prfuston 
imaKing. 
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heart chambers. The search for contrast agents that can yield 
left heart conttxt after intravenous injection is thus related 
to the search for nontoxic and stable microbubbles of 
diameter approximately 2 to 8 pm. 
Feinstein et al. (6) reported in 1984 that high intensity 
uitrasomc exposure of various liquids could provide such a 
nticrobubble suspension and that wnicsred diatriroate 
meglumine (Renografm) and albumin could yield left heat 
contrast after intravenous injections in animals (7.8). Other 
investigators (9-l I) recently showed contrast in the left 
heart chambers after peripheral wtous injection of new 
echo contrast agents. Further. initial human studies have 
shown that the commercial preparation Albunex (Molecular 
Biosystems) indeed yields left heart contrast after inttave- 
nous injections 112). 
However, despite the recent progress in the development 
of new echo contrast awnts capable of pulmonary ttattsmis- 
sion. there has been Ii&d stkss in-achieving repradttc- 
ible and qunntifiable myocardial opacification after injections 
of these agents (13.14). Although further advances in the 
noninvasive a~sewneot of regional myocardial perfusion 
will continue to be limited by the available contrast agents 
(15), the role of the other factors needs to be studied further. 
We thus designed the following study to investigate the 
transpulmonary transmission of sonicated albumin and to 
study the temporal and regional behavior of echocardio- 
graphic contrast in the left ventricle after intravenous injec- 
tions of sonicated albumin in humans. 
Methods 
the peak of the R wave an the ECG and end-systole 
(corresponding to the smallest left ventricular cavity area). 
For the sludy of cardiac cyclic variability of left ventricular 
contrast, the cardiac cycle with peak left ventricular contrast 
enhancement was identified. Two areas of interest were 
traced within the left ventricular cavity, one at the base and 
one at the apex. The endocardial border and mitral valve 
apparatus were carefully excluded from the tracings. The 
videodensitv within the two areas of interest was determined 
frame by frame over three consecutive cardiac cycles (the 
cardiac cvcle with peak left ventricular contrast enhance- 
Study subjects. After the protocol was approved L-y the ment and the preceding and following cycles). Videodensity 
Human Subjects Committee and the subjects gave signed measurements were computed at three defined points of the 
informed cansent, nine normal adult male volunteers with a cardiac cycle showing maximal contrast: at peak videoden- 
mean age of 38 years (range 26 to 561 were studied. None had sity (in early diastole). at end-diastole and at end-systole. 
heat? disease as assessed by history, physical examination. Vidcodensitomefric analysis of myocurdial conlr(lst was 
electrocardiography or echocardiography. performed at end.diastole, at baseline before contrast injec- 
Echocardiographic conirast agent preparation. A model lion and after peak left ventricular contrast enhancement. 
W-315 sonicelor (Heat Systems-Ultrasonics) with a 0.5 in. Because intense contrast enhancement in the right ventricle 
11.21 cm) diameter horn was used to eeneratc microbubbles. could affect the ultrasound image from regions of the under- 
ien mill/liters of 5% human albumio~American Red Cross) lying ventricle, an area of in&t was selected within the 
was sonicated for 75 s with the use of a sonicating chamber lateral wall of the left ventricle. 
and technique previously described (16). This method pro- Transit rime (in seconds) was derived from injections that 
duced a stable echocardiographic cootrat agent that con- resulted in left ventricular contrast and was defined as the 
tained microbubbles with a diameter of S.2 2 2.6 rrm (mean time from intravenous injection to the arrival of left ventric- 
r SD) by Coulter counter. ular contrast. 
Fxhocardiagraphic technique. Subjects were studied in 
the left lateral decubitus position. Two-dimensional echocar- 
diographic images were obtained with a Toshiba SSH-@I 
instrument equipped with a 3.5 MHz transducer. An apical 
four chamber view was used. The gain settings were ad- 
justed at the beginning of each study and kept unchanged 
throughout the study. All echocardiognphic images were 
recorded on videotape for subsequent analysis. Baseline 
recordings were obtained; thereafter. recording started be 
fore injection and continued for at least 30 s after injection of 
the contrast aye”,. 
Stalistical analysis. The Wilcoxon signed rank soot test 
was used to compare videodensity measureroents. Data are 
presented as mean values f SD: statistical significance is 
defined as P < 0.05. 
Side elfeels. No subject experienced any symptoms after 
infwenous injections of son&ted albumin. There were no 
sianificant changes in heart rate, blood oressure or the ECG 
Results 
Study pro&l. Hand injections of 0.08 ml/kg body after contrast injections. The echocardiogram revealed no 
weight of sonicated albumin performed through an I8 gauge regional wall motion abnormalities in a four chamber view. 
catheter inserted into a right brachial vein were followed by Right ventricular contrast and transpulmonaq conlrwl 
a rapid Rush of 7 ml of normal saline solution. All injections trsnsmission. All injections resulted in right ventricular con- 
were made by the same investigator. The electrocardiogram trast. Excessive right ventricular contrast that resulted in 
(ECG) was continuously monitored and blood pressure and lateral shadowing was observed in all but one injection. 
heart rate were recorded immediately bcforc sod after each Mean peak right ventricular videodensity was 75 * 48 at 
injection. end-diastole and 61 + 36 gray scale U/pixel at end-systole 
Eehoeardiographic data analysis. Echocardiograms were (p < 0.05). Seven (78%) of the nine intravenous injections 
analyzed off line with the use of a commercially available resulted in left ventricular contrast with a mean peak left 
computer system (MicroSonics DalaVuc). Echo contrast ventricular videodensity of 21 f 33 gray scale U/pixel. 
opacification was graded quantitatively by videodensitome- Contrast transit time was 6.4 + 3.2 s (range 3 to I IL 
try with the use of a software package fo; videodensity Myocardial cootPast opntication. No injection resulted 
analysis based on a level of 256 gray scale U. in myocardial contrast enhancement by visual or quantita- 
For qrtunrirukm of+! wn~ricrrlor contmst. an area of five analysis. Myocardial contrast vijeointensity was 9 2 IO 
interest was traced within the right ventricular cavity and at baseline and 8 + 9 gray scale U/pixel lp Z 0.05) after peak 
measurements were made at end-diastole (synchronized to left ventricular contrast enhancement. 
T*hlc I. car*m Cycle “arlabihly in Id, Yen,rlc”lrr wmca~ed albumm. Thirobcervanon. combnned with the ia& 
YideodenrQ &ray *ale Uipmell of vgnlhc*ni ude eRcts noted in our laboratory with 
Early Di*rto,e End~Dlrrfolr Ecd-Sy,,o,. ~ntracomnary wnicakd albumin (16.171 and at other iostiw 
Bare 35 I 39‘ 13 T 31’ 6 L 1” lions wing inlwenous Albunex (1% suggests that iotrave- 
Apex **II 17 T 13’ I?! noes wxicatrd albumin has acceptable :oxici!y. _ 
‘p < (I M ve,wut end.iy%“le. In our nme wlunleers all injections rewlied m right heart 
cootrat cnhaniement. Seventy-eight percent of mjections 
rowlIed m leil ventricular contrast cnhanccmcnt. WC ob- 
Cyclic variability of left ventricular contrast. Six of the xrvcd *~dc inlerrubject variability in the eficacy of 
seven injections that resulted in left ventricular coo!r&t Iranspuimonary transmission of echocardiographic contrast 
were of an intensity suitable for analy~s. Vidcodewty and a cigmficanr decrease in left ventricular contrast mten- 
measurements al three defined points in the cardiac cycle ore sty. as compared with right ventricular intensity. Keller et 
summarized in Table I. After the echo cootrat appeared m al. (8) also noted a transpulmonery loss of 61% of the 
the left atrium after intravenous injection. a rapld mcrcax m contrast efiect after intravenous injection of sonicated albu- 
left ventricular contrast intensity was seen after opening of mm in dog,. The failure of 22% of right-sided injeclions to 
the mitral valve (peak videodensity of 35 2 39 gray scale opacify the left ventricle could not be predicted by the extent 
U/pixel at the base). This was followed by o decrease III of right hczarr opacdficalion. Recause 811 iojectionc were 
videodensity at the base of the left ventricle associated with performed u~o a large anrecubital vein. the role of the 
a gradual increase in cootrat in the aptcal region (peek Injection ate was not evaluated in this stndy. However. 
videodensity 21 f 27 gray scale U/pixel). A secondary other uwc~t~garors 1141 have reponed that penpheral iotra- 
increase in lefl ventricular contrast intensity was observed venous iqections of an echo contrast agent are as efficacious 
after atrial contraction. In early systole a rapid decrease m a right heart or pulmonary injections. It is hoped that fulure 
left ventricular contrast intensity was observed at the left commercial qems will help achieve denser and more coo- 
ventricular base and apex associated with almoSt total dis- sistem left ventricular opaciiicmion. 
appearance of coolcast by end-systole (from 23 + 33 and 17 Cardiac cyclic variation in ventricular contrast intensity. 
2 23 at end-diastole to 6 ? IO and 3 c 2 gray scale U/pixel The later peak in videodensity observed in the apical left 
at end systole. at the base and apex. respectively. p < 0.05). ventricular TampIe volume. as compared with ihe basal 
This cyclic variab;lity in left ventricular contrast intensity aample volume. is related to mflow. In early dlastole a new 
and systolic loss of echo c ntrast is demonstrated over two contrast bolus fmm the left atrium first enters the basal 
crudiac cycles in Figures I and 2. sample volume and pauses an carlicr peak than is found in 
rhe apical left ventricular sample volume. The mid-diastolic 
contrast mtcrnity rcpresenrs the combination of new con- 
Discussion !rast influr from the left atrium and contrast redistribution 
Safely and oEicacy. In the small group of v~l~nt~~r~ 
studied. there were no adverse reactions to intravenous 
toward the cardiac apex. ‘The next effect is a decrease in 
mid-diastolic contrast intensity in the basal region of the left 
ventricle. Atrial contraction results in a secondary increase 
in left ventrxular cootrast inlene!ty and systole almost 
enlirely clean it. 
77w <IIII~ of rhr swrolic dwrenrr in /e.fI waricnlar 
co~~~r~~~f hrrrmiry is probably due to the dearuction of the 
albumin-coaled microbubbles by high left ventricular sys- 
tobc pressure. Studies at the University of Indiana also 
noted that left ventricular contrast intensity after infrave- 
noos mieclions nearly disappears in systole (Armstrong W. 
personal commuoica~ion. 1~88). Other possible explanations 
for contrast disappearance in syrtole should be considered. 
such as microbubble adherence to the left ventricular wall 
and mlcrobubble coa!escencc. However. these are unlikely 
when one considers the dramatic decrease in contrast inten- 
sitv in )vstole but not in diastole. We also observed a 
systolic decrase in contrast intensity in the Tight ventr&. 
This dare&e was small compared with that in the left 
ventricle and did not result in total disappearance ofcontrast 
mtentity in <ystole. This finding implies a finer degree of 
cuws of wicated albumin and pressure: the higher the 
pressure, rhe more rapid the disappearance of contrast. 
Contrast decay was mnst rapid at pressures 260 mm Hg. 
Moreover, pressure release aftrr contrast disappearance did 
not wult in contra61 reappearance. These in vitro data 
further suggest hat high ventricular pressures may result in 
the deslruction of microbubbles. 
lmplicalions of microbubble destruction due to systolic 
prerrure. The observation of the systolic disappearance of 
left venlricularcontrast intensity after transpulmonary irans- 
mission has profound implications for the clinical goal of 
achieving myocardial opacitication by intravenous injec- 
tions. Microbubble dewuction due to exposure to hiqh 
pressures during a single cardiac syslole would enptain thL 

